Literature DB >> 131665

Immunological capacity of lymphocytes from untreated patients with Hodgkin's disease evaluated in mixed lymphocyte culture.

M Björkholm, G Holm, H Mellstedt, D Pettersson.   

Abstract

Blood lymphocytes from thirty-nine untreated patients with Hodgkin's disease were tested for stimulatory and responding capacity in mixed lymphocyte culture. The response to allogeneic lymphocytes was impaired in ten patients but the mean response of the patient group did not differ from healthy controls. Lymphocytes from female patients responded better than male patients (P less than 0-02). The stimulatory efficacy was severely impaired in patients' lymphocytes (P less than 0-001). Age, clinical stage and histopathology had no significant influence on the responding or stimulatory capacity.

Entities:  

Mesh:

Year:  1975        PMID: 131665      PMCID: PMC1538427     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.

Authors:  H Rühl; W Vogt; G Bochert; S Schmidt; R Moelle; H Schaoua
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

2.  Studies on delayed hypersensitivity in Hodgkin's disease.

Authors:  A C AISENBERG
Journal:  J Clin Invest       Date:  1962-11       Impact factor: 14.808

3.  SEPARATION OF VIABLE LYMPHOCYTES FROM HUMAN BLOOD.

Authors:  A S COULSON; D G CHALMERS
Journal:  Lancet       Date:  1964-02-29       Impact factor: 79.321

Review 4.  HODGKIN'S DISEASE--PROGNOSIS, TREATMENT AND ETIOLOGIC AND IMMUNOLOGIC CONSIDERATIONS.

Authors:  A C AISENBERG
Journal:  N Engl J Med       Date:  1964-03-19       Impact factor: 91.245

5.  Delayed-type hypersensitivity and the immunology of Hodgkin's disease, with a parallel examination of sarcoidosis.

Authors:  M W Chase
Journal:  Cancer Res       Date:  1966-06       Impact factor: 12.701

6.  Stimulatory capacity of human T and B lymphocytes in the mixed leukocyte culture.

Authors:  H P Lohrmann; L Novikovs; R G Graw
Journal:  Nature       Date:  1974-07-12       Impact factor: 49.962

7.  Mixed-lymphocyte reaction as assay for immunological competence of lymphocytes from patients with hodgkin's disease.

Authors:  J M Lang; F Oberling; M M Tongio; S Mayer; R Waitz
Journal:  Lancet       Date:  1972-06-10       Impact factor: 79.321

8.  B lymphocytes as stimulators of a mixed lymphocyte reaction.

Authors:  C Cheers; J Sprent
Journal:  Transplantation       Date:  1973-03       Impact factor: 4.939

9.  Impaired in vitro lymphocyte transformation in Hodgkin's disease.

Authors:  E M Hersh; J J Oppenheim
Journal:  N Engl J Med       Date:  1965-11-04       Impact factor: 91.245

Review 10.  Allograft response in vitro.

Authors:  P Häyry; L C Andersson; S Nordling; M Virolainen
Journal:  Transplant Rev       Date:  1972
View more
  4 in total

1.  Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.

Authors:  S Romagnani; G F Del Prete; E Maggi; G Bellesi; G Biti; P L Rossi Ferrini; M Ricci
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

2.  Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.

Authors:  E G Engleman; C J Benike; R T Hoppe; H S Kaplan; F R Berberich
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

3.  Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.

Authors:  S M Hillinger; G P Herzig
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

4.  Increased monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) in Hodgkin's disease.

Authors:  H Pehamberger; H Ludwig; P Pötzi; W Knapp
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.